Hyperleukocytosis, a rare manifestation of autoimmune hemolytic anemia

Hyperleukocytosis and autoimmune hemolytic anemia

Authors

  • Sema Yilmaz Health Science University, Kartal Dr. Lutfi Kirdar City Hospital
  • Ilknur Uzunoglu Health Science University, Kartal Dr. Lutfi Kirdar City Hospital, Pediatrics, Istanbul, Turkey
  • Nursima Cukadar Health Science University, Kartal Dr. Lutfi Kirdar City Hospital, Pediatrics, Istanbul, Turkey
  • Egemen Tavrak Health Science University, Kartal Dr. Lutfi Kirdar City Hospital, Pediatrics, Istanbul, Turkey
  • Elif Suleymanoglu

Keywords:

autoimmune hemolytic anemia, child, leukocytosis, mycoplasma

Abstract

Autoimmune hemolytic anemia (AIHA) is characterized by the binding of antibodies to red blood cell (RBC) surface antigens and initiate RBC destruction. White blood cell is usually normal and hyperleukocytosis is rare. The most common microorganism that has been associated with these hemolytic processes are Mycoplasma pneumoniae. Here, we repored a 4-year-old boy child who diagnosed AIHA by warm antibody testing with leukocytosis. The patient was treated with metylprednisolone, intravenous immunoglobulin and clarithromycin. During treatment, the leukocytosis returned to the normal range. The clinical condition and vital signs improved. The purpose of this study is to highlight hyperleukocytosis in AIHA caused by Mycoplasma pneumoniae.

Downloads

Published

2020-10-27

How to Cite

Yilmaz, S., Uzunoglu, I. ., Cukadar, N., Tavrak, E., & Suleymanoglu, E. . (2020). Hyperleukocytosis, a rare manifestation of autoimmune hemolytic anemia: Hyperleukocytosis and autoimmune hemolytic anemia. Pakistan Journal of Medicine and Dentistry, 9(4), 90–93. Retrieved from http://ojs.zu.edu.pk/ojs/index.php/pjmd/article/view/485

Issue

Section

Case Report

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.